Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.

[1]  E. De Clercq.  Interferon and Its Inducers—A Never-Ending Story: “Old” and “New” Data in a New Perspective , 2006, The Journal of infectious diseases.

[2]  I. Blasig,et al.  In Search of the Astrocytic Factor(s) Modulating Blood–Brain Barrier Functions in Brain Capillary Endothelial Cells In Vitro , 2005, Cellular and Molecular Neurobiology.

[3]  C. Cheney,et al.  Modeling hamsters for evaluating West Nile virus therapies. , 2004, Antiviral research.

[4]  D. Smee,et al.  Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models , 2004, Antiviral chemistry & chemotherapy.

[5]  M. Lakomek,et al.  Alkylglycerol opening of the blood–brain barrier to small and large fluorescence markers in normal and C6 glioma‐bearing rats and isolated rat brain capillaries , 2003, British journal of pharmacology.

[6]  G. Atkins,et al.  Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection. , 2003, Veterinary immunology and immunopathology.

[7]  M. Drebot,et al.  West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  E. De Clercq,et al.  Interferons, Interferon Inducers, and Interferon-Ribavirin in Treatment of Flavivirus-Induced Encephalitis in Mice , 2003, Antimicrobial Agents and Chemotherapy.

[9]  P. Kozler,et al.  Altered blood-brain barrier permeability and its effect on the distribution of Evans blue and sodium fluorescein in the rat brain applied by intracarotid injection. , 2003, Physiological research.

[10]  D. Smee,et al.  Identification of active antiviral compounds against a New York isolate of West Nile virus. , 2002, Antiviral research.

[11]  D. Asnis,et al.  The West Nile Virus Encephalitis Outbreak in the United States (1999‐2000) , 2001 .

[12]  R. Rybak,et al.  Intravenous Infusion of Cereport Increases Uptake and Efficacy of Acyclovir in Herpes Simplex Virus-Infected Rat Brains , 2001, Antimicrobial Agents and Chemotherapy.

[13]  D. Asnis,et al.  The West Nile virus encephalitis outbreak in the United States (1999-2000): from Flushing, New York, to beyond its borders. , 2001, Annals of the New York Academy of Sciences.

[14]  H. Guzmán,et al.  West Nile Virus West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis , 2022 .

[15]  M. Deli,et al.  Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood-brain barrier permeability in the rat. , 2000, European journal of pharmacology.

[16]  C. Achim,et al.  Blood–brain barrier disruption in simian immunodeficiency virus encephalitis , 2000, Neuropathology and applied neurobiology.

[17]  D. Ben-Nathan,et al.  CNS Penetration by Noninvasive Viruses Following Inhalational Anesthetics , 2000, Annals of the New York Academy of Sciences.

[18]  C. Achim,et al.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[19]  K. Conant,et al.  Cerebrospinal fluid levels of MMP‐2, 7, and 9 are elevated in association with human immunodeficiency virus dementia , 1999, Annals of neurology.

[20]  R. Agarwal,et al.  Functional impairment of blood-brain barrier following pesticide exposure during early development in rats , 1999, Human & experimental toxicology.

[21]  R. Salonen,et al.  Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest ( A7) virus infection facilitates the development of experimental allergic encephalomyelitis , 1996, Journal of Neuroimmunology.

[22]  D. Smee,et al.  Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. , 1994, Antiviral research.

[23]  Y. Kafri,et al.  Viral neuroinvasion and encephalitis induced by lipopolysaccharide and its mediators , 1992, The Journal of experimental medicine.

[24]  M. Brinton,et al.  Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection. , 1991, Antiviral research.

[25]  A. Thomsen,et al.  Breakdown of blood-brain barrier function in the murine lymphocytic choriomeningitis virus infection mediated by virus-specific CD8+ T cells , 1991, Journal of Neuroimmunology.

[26]  M. Brinton,et al.  Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. , 1990, Journal of interferon research.

[27]  M. Brinton,et al.  Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses. , 1988, International journal of immunopharmacology.

[28]  C. Calisher.  Arthropod-Borne and Rodent-Borne Viral Diseases: WHO Technical Report Series No. 719, by the World Health Organization. 116 pages. The World Health Organization, 1211 Geneva 27, Switzerland. 1985. $4.50 , 1986 .